References
- Neves-e-Castro M. Menopause in crisis post-WHI? A view based on personal clinical experience. Hum Reprod 2003; 18: 2512–2518
- Parker-Pope T. How NIH misread hormone study in 2002. Wall Street Journal Jul 9, 2007; 81
- Neves-e-Castro M. My dream. Climacteric 2004; 7: 322–323
- Hsia J, Langer R, Manson J, Kuller L, Johnson K C, Hendrix S L, Pettinger M, Heckbert S R, Greep N, Crawford S, , Women's Health Initiative Investigators, et al. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 2006; 166: 357–363
- Manson J E, Allison M, Rossouw J, Carr J J, Langer R D, Hsia J, Kuller L H, Cochrane B B, Hunt J R, Ludlam S E, , WHI and WHI-CACS Investigators, et al. Estrogen therapy and coronary-artery calcification. New Engl J Med 2007; 356: 2591–2602
- Rossow J. Symposium at Harvard School of Public Health (2003) quoted by Gina Kolata in New York Times April 22, 2003.
- Creasman W T, Hoel D, DiSaia P J. WHI: now that the dust has settled: a commentary. Am J Obstet Gynecol 2003; 189: 621–626
- MacLennan A, Sturdee D. Editorial: The End of Wisdom. Climacteric 2002; 5: 313–316
- Vickers M, MacLennan A, Ford D, Ford D, Martin J, Meredith S K, Destavola B L, Rose S, Dowell A, Wilkes H C, , WISDOM team, et al. Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women. Br Med J Jul 23, 2007, [Epub ahead of print]
- Mikkola T S, Clarkson T B. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002; 53: 605–619
- Grodstein F, Manson J, Stampfer M. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health 2006; 15: 35–44
- Neves-e-Castro M. Conclusions of the 3rd International Symposium of the Portuguese Menopause Society. Maturitas 2005; 51: 38–39
- Speroff L. The future of postmenopausal hormone therapy: it's time to move forward. Maturitas 2007; 57: 103–106
- Pines A. Postmenopausal hormone therapy: the way ahead. Maturitas 2007; 57: 3–5
- Stevenson J. HRT and the primary prevention of cardiovascular disease. Maturitas 2007; 57: 31–34
- Pines A, Sturdee D, MacLennan A. The heart of the WHI study: time for hormone therapy policies to be revised. Climacteric 2007; 10: 267–269
- Pines A, Sturdee D, Birkhauser M. Postmenopausal hormone therapy and coronary disease – the truth of the matter. IMS Press Statement Jun 20, 2007
- Board of the International Menopause Society, Pines A, Sturdee D W, Birkhäuser M H, Schneider H P, Gambacciani M, Panay N. IMS updated recommendations on postmenopausal hormone therapy. Climacteric 2007; 10: 181–194
- Pines A, Sturdee D, Birkhauser M. Hormone therapy and cardiovascular disease in the early postmenopause: the WHI data revisited. Climacteric 2007; 10: 195–196
- Gompel A, Barlow D, Rozenberg S, Skouby S O, EMAS Executive Committee. The EMAS 2006/2007 update on clinical recommendations on postmenopausal hormone therapy. Maturitas 2007; 56: 227–229
- NAMS Position Statement. Estrogen and progestogen use in peri-and postmenopausal women: March 2007 position statement. Menopause 2007; 14: 168–182